Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study

Ajai Chari, Cyrille Touzeau, Carolina Schinke, Monique C Minnema, Jesus G Berdeja, Albert Oriol, Niels W C J van de Donk, Paula Rodríguez-Otero, Daniel Morillo, Carmen Martinez-Chamorro, María-Victoria Mateos, Luciano J Costa, Jo Caers, Leo Rasche, Amrita Krishnan, Jing Christine Ye, Lionel Karlin, Brea Lipe, Deeksha Vishwamitra, Sheri Skerget, Raluca Verona, Xuewen Ma, Xiang Qin, Hein Ludlage, Michela Campagna, Tara Masterson, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Jenna D Goldberg, Colleen Kane, Christoph Heuck, Jesus San-Miguel, Philippe Moreau

Open source

DOI: 10.1016/s2352-3026(24)00385-5
Published: 2025-04
Container: The Lancet Haematology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3026-24-00385-5,
  title = {Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study},
  author = {Ajai Chari and Cyrille Touzeau and Carolina Schinke and Monique C Minnema and Jesus G Berdeja and Albert Oriol and Niels W C J van de Donk and Paula Rodríguez-Otero and Daniel Morillo and Carmen Martinez-Chamorro and María-Victoria Mateos and Luciano J Costa and Jo Caers and Leo Rasche and Amrita Krishnan and Jing Christine Ye and Lionel Karlin and Brea Lipe and Deeksha Vishwamitra and Sheri Skerget and Raluca Verona and Xuewen Ma and Xiang Qin and Hein Ludlage and Michela Campagna and Tara Masterson and Brandi Hilder and Jaszianne Tolbert and Thomas Renaud and Jenna D Goldberg and Colleen Kane and Christoph Heuck and Jesus San-Miguel and Philippe Moreau},
  year = {2025},
  journal = {The Lancet Haematology},
  doi = {10.1016/s2352-3026(24)00385-5},
  url = {https://doi.org/10.1016/s2352-3026(24)00385-5}
}

RIS

TY  - JOUR
TI  - Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study
AU  - Ajai Chari
AU  - Cyrille Touzeau
AU  - Carolina Schinke
AU  - Monique C Minnema
AU  - Jesus G Berdeja
AU  - Albert Oriol
AU  - Niels W C J van de Donk
AU  - Paula Rodríguez-Otero
AU  - Daniel Morillo
AU  - Carmen Martinez-Chamorro
AU  - María-Victoria Mateos
AU  - Luciano J Costa
AU  - Jo Caers
AU  - Leo Rasche
AU  - Amrita Krishnan
AU  - Jing Christine Ye
AU  - Lionel Karlin
AU  - Brea Lipe
AU  - Deeksha Vishwamitra
AU  - Sheri Skerget
AU  - Raluca Verona
AU  - Xuewen Ma
AU  - Xiang Qin
AU  - Hein Ludlage
AU  - Michela Campagna
AU  - Tara Masterson
AU  - Brandi Hilder
AU  - Jaszianne Tolbert
AU  - Thomas Renaud
AU  - Jenna D Goldberg
AU  - Colleen Kane
AU  - Christoph Heuck
AU  - Jesus San-Miguel
AU  - Philippe Moreau
PY  - 2025
JO  - The Lancet Haematology
DO  - 10.1016/s2352-3026(24)00385-5
UR  - https://doi.org/10.1016/s2352-3026(24)00385-5
ER  -

APA

Chari, A., Touzeau, C., Schinke, C., Minnema, M. C., Berdeja, J. G., Oriol, A., Donk, N. W. C. J. V. D., Rodríguez-Otero, P., Morillo, D., Martinez-Chamorro, C., Mateos, M., Costa, L. J., Caers, J., Rasche, L., Krishnan, A., Ye, J. C., Karlin, L., Lipe, B., Vishwamitra, D., Skerget, S., Verona, R., Ma, X., Qin, X., Ludlage, H., Campagna, M., Masterson, T., Hilder, B., Tolbert, J., Renaud, T., Goldberg, J. D., Kane, C., Heuck, C., San-Miguel, J., & Moreau, P. (2025). Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study. The Lancet Haematology. https://doi.org/10.1016/s2352-3026(24)00385-5

Source records

crossref · retrieved 2026-09-26T12:36:20.987Z